NRGENE TECHNOLOGIES LTD
TTASE:NRGN67.00
ILA
0.00
(0.00%)
ISIN
IL0011720716
Return %
Stock
S&P 500
1Y
-76.64
14.20
3Y
-64.11
81.12
5Y
-94.38
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Semi-annual Revenue
USD
•
in mil. unless spec.Semi-annual Earnings Per Share
USD
•
in mil. unless spec.Semi-annual Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Gil Ronen
- Full Time Employees
- 23
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- Golda Meir Street Ness Ziona HM Israel 7403649
- IPO Date
- Jan 28, 2021
- Website
- nrgene.com
- Similar Companies
- Business
- NRGene Technologies Ltd (NRGN.TA) is an Israel-based AgTech company specializing in AI-driven genomics for accelerating and improving the natural breeding of crops and animals in the global agriculture and food industries. Founded in 2009 and headquartered in Ness Ziona, the company develops advanced computational tools, proprietary algorithms, and software platforms including GenoMAGIC, TraitMAGIC, SnPer, SnPro, Soy SNPro, and Canola Pro; it offers customized genotyping solutions, genome assemblies, genomic mapping, diversity analysis, trait mapping, prediction services, and turnkey solutions for breeding programs targeting key crops such as wheat, canola, corn, soybean, maize, tomatoes, strawberries, legumes, peanuts, stevia, and cannabis, as well as animals and insects like black soldier fly. NRGene serves leading breeding companies, AgTech and food-tech firms, academia, research institutes, and agribiotech entities worldwide across North America, Europe, the Middle East, Africa, Asia Pacific, with subsidiaries in the United States, Canada, and Germany, including a genotyping lab in Saskatoon; its vast proprietary database supports over 300 completed projects, enhancing sustainable food production by improving crop resilience, water efficiency, nutritional profiles, yield, shelf life, and reducing environmental footprints. Recent developments include a 2023 asset purchase agreement with Above Food Corp. for AI-based genomic assets, intellectual property, and trait technology licensing rights including clubroot-resistant canola germplasm, high-protein traits, and DNA markers, with NRGene Canada R&D team integration pending Above Food's business combination completion; strategic collaborations with Bühler for black soldier fly genetics and processing, Top Seeds International (Mitsui & Co.), Granot Group for vertical farming varieties, and ongoing advancements like ToBRFV trait mapping in tomatoes and non-allergenic wheat and peanuts. The company listed on the Tel Aviv Stock Exchange via IPO and maintains global operations focused on IP-intensive trait and variety commercialization.